Best Water for Your Kidneys: Alkaline, Hydrogen, or Tap

https://youtu.be/YOrqsMyuCC0

The short answer

Plain tap water is the best water for your kidneys, and how much you drink matters more than the label. When researchers randomly assigned 631 adults with stage 3 kidney disease to drink more water for a year, kidney function fell at the same rate in both groups. Neither alkaline nor hydrogen water has a randomized human trial showing it protects kidneys, so the premium buys nothing measurable. Two exceptions are real: if you form kidney stones, or you have polycystic kidney disease, your fluid intake genuinely changes your outcome.

What we cover

●      Why the CKD WIT randomized trial found a year of drinking more water did not slow kidney decline in 631 adults. (JAMA, 2018)

●      Why water intake and kidney failure follow a U-shaped curve, so very high plain-water intake tracks with faster decline. (Nephrology Dialysis Transplantation, 2022)

●      Who is most at risk of pushing blood sodium too low: older adults and anyone on water pills or certain blood pressure medicines.

●      What the human evidence on alkaline and hydrogen water in kidney disease amounts to, and why tap has never been shown to be worse.

●      The one grain of truth under the alkaline pitch, and why prescribed sodium bicarbonate corrects blood acid when a bottle cannot.

●      How raising fluid to about 2.5 liters of urine a day cut stone recurrence by roughly half over five years. (Journal of Urology, 1996)

●      Why polycystic kidney disease responds to hydration, but tolvaptan rather than tap water is the therapy with evidence. (Kidney360, 2026 and Renal Failure, 2025)

●      The single swap, one daily soda for water, linked to lower kidney disease risk in more than 127,000 people. (JAMA Network Open, 2024)

Timestamps

00:00 The water myth, tested in a trial

01:16 The CKD WIT trial: 631 people, randomized

04:03 The quick answer on alkaline and hydrogen water

04:33 Why more water can backfire: the CKD-REIN study

08:11 Why alkaline and hydrogen water get sold as kidney medicine

09:09 Alkaline water's one grain of truth

12:03 Kidney stones: the five-year trial

13:36 Polycystic kidney disease and vasopressin

References

In 631 adults with stage 3 kidney disease, coaching to drink more water raised urine output by 0.6 liters a day and lowered copeptin, yet eGFR decline was no slower, an adjusted between-group difference of -0.3 mL/min/1.73m2 (95 percent CI -1.8 to 1.2, P = 0.74).

Clark WF, Sontrop JM, Huang SH, et al. Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With CKD: The CKD WIT Randomized Clinical Trial. JAMA. 2018;319(18):1870-1879. PMID 29801012. https://doi.org/10.1001/jama.2018.4930 (randomized trial).

Across 1,265 people with chronic kidney disease, kidney failure risk was lowest at 1.0 to 1.5 liters of plain water a day, with adjusted hazard ratios of 1.88 below 0.5 liters and 1.55 above 2.0 liters against that reference.

Wagner S, Merkling T, Metzger M, et al. Water intake and progression of chronic kidney disease: the CKD-REIN cohort study. Nephrology Dialysis Transplantation. 2022;37(4):730-739. PMID 33576809. https://doi.org/10.1093/ndt/gfab036 (observational cohort; shows association, not causation).

In 199 calcium stone formers randomized for five years, recurrence was 12 of 99 with high fluid intake against 27 of 100 in controls (P = 0.008), achieved at about 2.5 liters of urine a day.

Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. Journal of Urology. 1996;155(3):839-843. PMID 8583588. https://pubmed.ncbi.nlm.nih.gov/8583588/ (randomized trial).

Among 311 people with autosomal dominant polycystic kidney disease followed five years, the highest quartile of serum osmolality, meaning the most concentrated, carried 5.91 times the risk of a 40 percent eGFR decline.

Fung WW, Chow KM, Li PK, Szeto CC. The Relationship of Osmolality and Kidney Outcomes in Patients with Autosomal Dominant Polycystic Kidney Disease. Kidney360. 2026;7(5):1095-1103. PMID 41678280. https://doi.org/10.34067/KID.0000001126 (observational cohort; causality not established).

Tolvaptan, a vasopressin V2-receptor antagonist, is the only approved disease-modifying therapy for autosomal dominant polycystic kidney disease, and high water intake is not an approved substitute for it.

Borghol AH, Bou Saba J, Kalaydjian S, et al. Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances. Renal Failure. 2025;47(1):2492374. PMID 40268755. https://doi.org/10.1080/0886022X.2025.2492374 (narrative review).

Among 127,830 UK Biobank participants followed a median of 10.5 years, more than one sugar-sweetened drink a day carried an adjusted hazard ratio of 1.19 for new chronic kidney disease, and replacing one serving with water was associated with hazard ratios of about 0.91 to 0.93.

Heo GY, Koh HB, Park JT, et al. Sweetened Beverage Intake and Incident Chronic Kidney Disease in the UK Biobank Study. JAMA Network Open. 2024;7(2):e2356885. PMID 38416492. https://doi.org/10.1001/jamanetworkopen.2023.56885 (observational cohort; shows association, not causation).

When to see a doctor

If your urine turns pink or brown, you are suddenly making far less urine than usual, or your ankles and face start swelling, call your kidney team or your doctor rather than trying to treat it with water.

Get my free kidney health guide: guides.selfprinciple.org/kidney

This content is for educational purposes only and is not medical advice. Always consult your healthcare provider for individual care. The views expressed are Dr. Hashmi's own and do not represent his employer.